Know Cancer

or
forgot password

Effect of Hippocampal Sparing on Neurocognitive Functions and Quality of Live in Patients Irradiated in the Neurocranial Area


Phase 2
18 Years
N/A
Open (Enrolling)
Both
Radiation of Neurocranial Region

Thank you

Trial Information

Effect of Hippocampal Sparing on Neurocognitive Functions and Quality of Live in Patients Irradiated in the Neurocranial Area


Inclusion Criteria:



- minimum age 18

- diseases indicating a radiotherapy of neurocranial area (histologically or
image-guided confirmed (skull base)meningioma,pituitary adenoma,brain metastases,
SCLC)

- indication for a local radiotherapy in neurocranial area or for a radiation of whole
neurocranium

- Karnofsky-State ≥ 50%

- patient has understand content of study protocol

- Signed study-specific consent form prior to therapy

Exclusion Criteria

- pregnant or nursing women

- Fertile patients who refuse effective contraception during study treatment

- persistent drug and/or alcohol abuse

- prior radiotherapy of neurocranial region

- patients not able or willing to behave according to study protocol

- in the case of malignancy: more than 3 brain metastases

- in the case of malignancy: brain metastases in hippocampal region or in the
hippocampus avoidance zone

- GTV in hippocampal region or in the hippocampus avoidance zone

- patients in care

- patients who are not able to speak German

- conditions that preclude the application of MRT (e.g. magnetic implants, cardiac
pacemaker)

- on-treatment participation on other trials

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

quality of live and neurocognitive functions

Outcome Time Frame:

Participants will be followed for the duration of therapy and for 5 years after the last study treatment

Safety Issue:

No

Principal Investigator

Rainer Fietkau, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Strahlenklinik, Universitätsklinikum Erlangen

Authority:

Germany: Ethics Commission

Study ID:

HIPSPA2013

NCT ID:

NCT01849484

Start Date:

March 2013

Completion Date:

April 2021

Related Keywords:

  • Radiation of Neurocranial Region
  • meningioma
  • skull base meningioma
  • pituitary adenoma
  • brain metastases
  • small cell lung carcinoma

Name

Location